Pricing Log in Create free account

MannKind Corporation (MNKD) vs Seaport Therapeutics, Inc (SPTX)

MannKind Corporation and Seaport Therapeutics, Inc are both Biotechnology companies. MannKind Corporation is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Seaport Therapeutics, Inc has the higher net margin (0.00% vs −18.1%) and the lower return on invested capital (−88.1% vs 0.00%). Across the 11 metrics below, Seaport Therapeutics, Inc leads on 6 and MannKind Corporation on 5.

Valuation

Metric MNKD SPTX Biotechnology median
P/E n/m n/m 10.60
P/S 3.04 n/m 9.40
P/B n/m 2.85 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 50.23 n/m 0.66
EV/Sales 3.82 n/m 9.02
Earnings yield (5.87%) (107.07%) (32.88%)
Free cash flow yield (6.25%) (8.47%) (23.13%)

Profitability

Metric MNKD SPTX Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin (2.88%) 0.00% 0.00%
Net margin (18.10%) 0.00% 0.00%
Free cash flow margin (18.97%) 0.00% 0.00%
Return on equity 182.90% (74.36%) (51.96%)
Return on assets (12.29%) (37.78%) (46.06%)
Return on invested capital 0.00% (88.12%) 0.00%

Growth

Metric MNKD SPTX Biotechnology median
Revenue growth (TTM) 31.74% — 6.76%
EPS growth (last fiscal year) (80.00%) 36.55% 29.88%
Revenue growth, 5-year CAGR 39.89% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MNKD SPTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.22 17.48 4.97
Net debt to EBITDA 5.32 2.42 1.01

Dividend

Metric MNKD SPTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MNKD SPTX Biotechnology median
Market cap 1.21b 1.09b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack